From April 1, 2021 to June 1, 2021, the company has repurchased 10,012 shares, representing 0.09% for KRW 112.63 million. With this, the company has completed the repurchase of 61,995 shares, representing 0.56% for KRW 616.17 million under the buyback announced on February 26, 2021.
DaebongLS Co Ltd is a Korea-based company primarily engaged in the manufacture of pharmaceutical and cosmetic ingredients. The Company operates its business through two segments. The Pharmaceutical Active Ingredient Business segment provides active pharmaceutical ingredients for respiratory treatments, hypertension treatments, and digestive system treatments. The Cosmetic Material Business segment manufactures and sells natural and functional cosmetic ingredients. In addition, the Company provides testing services for materials used on the skin and engages in real estate leasing business. The Company sells its products in domestic and overseas markets.
